Letter to the Editor
-
Issue: Blood Transfusion - 3 2020 (May-June)
Publication Date: 2020-05-07
A multimodal practical approach in a Transfusion Medicine Centre to face the COVID-19 outbreak
-
Issue: Blood Transfusion - 3 2020 (May-June)
Publication Date: 2020-05-07
Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial
-
Issue: Blood Transfusion - 3 2020 (May-June)
Publication Date: 2020-05-07
Use of eye drops obtained from homologous blood source in the time of COVID-19: is there cause for ophthalmological concern?
-
Issue: Blood Transfusion - 1 2019 (January-February)
Publication Date: 2018-11-07
Cost of Pathogen Reduction for platelets: reply to Cicchetti et al. Blood Transfus 2018; 16: 483-9
-
Issue: Blood Transfusion - 1 2019 (January-February)
Publication Date: 2018-04-04
On the cost-utility of methylene blue-photoinactivated plasma versus quarantine plasma in Spain
-
Issue: Blood Transfusion - 1 2019 (January-February)
Publication Date: 2017-12-22
Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis"
-
Issue: Blood Transfusion - 1 2019 (January-February)
Publication Date: 2017-10-03
Reply to "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis" by Messori et al.
-
Issue: Blood Transfusion - 1 2018 (January - February)
Publication Date: 2016-09-22
Preserved in vitro metabolic and functional characteristics of double-dose apheresis platelet concentrates photochemically treated with amotosalen and ultraviolet A light